Oligoastrocytoma

16 registered clinical trials studyying Oligoastrocytoma — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Gra NCT07031765	University of Florida	Phase 1
Recruiting	Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) G NCT04623931	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant NCT03180502	NRG Oncology	Phase 2
Withdrawn	NovoTTF-200A Device in Treating Patients With Newly Diagnosed High Risk Oligodendroglioma NCT03353896	University of Southern California	N/A
Completed	Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With NCT02530320	Grupo Español de Investigación en Neurooncología	Phase 2
Unknown	A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas NCT02209428	Huashan Hospital	Phase 2
Terminated	Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas NCT01849952	Dartmouth-Hitchcock Medical Center	—
Completed	Neural Basis of Language Processing NCT02903784	University Hospital, Montpellier	N/A
Terminated	(11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas NCT01281982	National Cancer Institute (NCI)	—
Completed	HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas NCT00874861	Ian F. Pollack, M.D.	EARLY_Phase 1
Unknown	FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma NCT01089244	Ludwig-Maximilians - University of Munich	—
Terminated	Treatment Strategy for Low-grade Gliomas NCT00897377	Sun Yat-sen University	Phase 3
Terminated	A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplast NCT00389090	Keryx / AOI Pharmaceuticals, Inc.	Phase 2
Completed	Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previo NCT00303849	OHSU Knight Cancer Institute	Phase 1 / Phase 2
Completed	IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Pat NCT00089427	INSYS Therapeutics Inc	Phase 1
Completed	Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide NCT00717210	Neuro-Oncology Working Group of the German Cancer Society	Phase 3